CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
The Armored RNA Quant SARS-CoV-2 Control targets the SARS-CoV-2 viral nucleocapsid (N) region and, along with the company’s RNAse P construct, aligns with the CDC- and WHO-recommended Diagnostic Panel (CDC-006-00019), the company says. Armored technology encapsulates the in vitro transcribed RNA in a protective protein coat to resist nuclease degradation.
Pages: 1 2